ID: ALA3628036

Max Phase: Preclinical

Molecular Formula: C25H34O7

Molecular Weight: 446.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)=CCC/C(C)=C/C(=O)OCC1=C2/C(=C\[C@@]3(C)CC[C@](O)(O3)[C@H](C)C[C@@H]2O)OC1=O

Standard InChI:  InChI=1S/C25H34O7/c1-15(2)7-6-8-16(3)11-21(27)30-14-18-22-19(26)12-17(4)25(29)10-9-24(5,32-25)13-20(22)31-23(18)28/h7,11,13,17,19,26,29H,6,8-10,12,14H2,1-5H3/b16-11+,20-13+/t17-,19+,24-,25+/m1/s1

Standard InChI Key:  HNEGIAHZLMYTNL-GAEBNKLVSA-N

Associated Targets(Human)

Signal transducer and activator of transcription 3 3313 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Signal transducer and activator of transcription 3 376 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Signal transducer and activator of transcription 1 63 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Signal transducer and activator of transcription 1/ 3 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 446.54Molecular Weight (Monoisotopic): 446.2305AlogP: 3.62#Rotatable Bonds: 6
Polar Surface Area: 102.29Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.83CX Basic pKa: CX LogP: 3.41CX LogD: 3.41
Aromatic Rings: 0Heavy Atoms: 32QED Weighted: 0.36Np Likeness Score: 2.73

References

1. Miklossy G, Youn UJ, Yue P, Zhang M, Chen CH, Hilliard TS, Paladino D, Li Y, Choi J, Sarkaria JN, Kawakami JK, Wongwiwatthananukit S, Chen Y, Sun D, Chang LC, Turkson J..  (2015)  Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.,  58  (19): [PMID:26331426] [10.1021/acs.jmedchem.5b00686]

Source